About this trial
The perinatal period is recognized as a time of heightened psychological vulnerability. This research aims to improve the diagnosis and therapeutic management of mood episodes occurring during this time. It is integrated into routine clinical care and seeks to standardize the evaluation of criteria used to characterize mood episodes, while also exploring relevant contextual factors.
Traditionally, clinical attention has focused on postnatal depression; however, increasing evidence highlights the presence of hypomanic symptoms-such as distractibility, reduced need for sleep, tachypsychia, and irritability-during the postpartum period. These symptoms may coexist with depressive features, resulting in complex clinical presentations that are often difficult to recognize and manage. Consequently, many cases go undiagnosed and untreated.
Current research has largely concentrated on depressive episodes (perinatal depression), with less emphasis on manic, hypomanic, or mixed episodes indicative of bipolar disorder. A systematic evaluation of hypomanic symptoms occurring alongside depressive symptoms in the postpartum period could refine clinical diagnosis and support more targeted and effective therapeutic interventions.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Women over 18 years old
Pregnant or having given birth less than a year ago
First psychiatric consultation for the pregnancy concerned.
Good command of the French language.
Disqualifiers
Women who gave birth more than a year ago.
Participant under psychiatric care
Participant under court protection
Trial design
Single group
Treatments tested in this trial
self-questionnaires
Other interventionPatients who volunteer to take part in the research will complete self-questionnaires before their appointment with the psychiatrist.
Treatment groups
Trial outcomes
Primary outcomes
Detailed description of the Edinburg Postnatal (EPDS) scale
A sensitivity analysis will be carried out on the group of patients with an EPDS score greater than 12, and a comparison between these patients and patients with an EPDS score equal to or less than 12 will also be carried out
Detailed description of Multidimensional Assessment of Thymic (MAThyS) scale
Secondary outcomes
Association of the risk factors Perceived Stress Scale (PSS) will be assessed by self-report
the level of perceived stress by self report score\>=14 characterize a high level of perceived stress
Association of the risk factors Medical Outcomes Study -Social Support Survey (MOS-SSS) will be assessed by self-report
the level of perceived social support by self-report scale scores can range from 19 to 95, with a median score of 57
Association of the risk factors Perceived Professional Social Support (QSSP-P) will be assessed by self-report
the level of perceived social support in the professional by self-report. scale scores pcan range from 12 to 120, with a median score of 66
Sponsors and contacts
Click on the lead sponsor to view all of their trials.